Literature DB >> 22116141

Chest wall abscess due to Mycobacterium bovis BCG after intravesical BCG therapy.

Hajime Kanamori1, Katsuhiko Isogami, Takashi Hatakeyama, Hiroo Saito, Kazuyoshi Shimada, Bine Uchiyama, Noboru Aso, Mitsuo Kaku.   

Abstract

We report a case of chest wall abscess caused by Mycobacterium bovis BCG that arose as a complication 1 year after intravesical BCG instillation. We identified M. bovis BCG Tokyo 172 in the abscess by PCR-based typing of Mycobacterium tuberculosis complex and analysis of variable number of tandem repeats data.

Entities:  

Mesh：

Year:  2011        PMID： 22116141      PMCID： PMC3264141          DOI： 10.1128/JCM.05888-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

1.  Skin abscess after intravesical instillation of bacillus Calmette-Guerin for prophylactic treatment of transitional cell carcinoma.

Authors:  B Mangiarotti; A Trinchieri; R Marconato; E Pisani
Journal:  J Urol       Date:  2002-09       Impact factor: 7.450

Review 2.  Theoretical and methodological aspects of BCG vaccine from the discovery of Calmette and Guérin to molecular biology. A review.

Authors:  L Lugosi
Journal:  Tuber Lung Dis       Date:  1992-10

3.  Complications after intravesical instillation of bacillus Calmette-Guerin: rhabdomyolysis and metastatic infection.

Authors:  R W Armstrong
Journal:  J Urol       Date:  1991-06       Impact factor: 7.450

4.  PCR-based method to differentiate the subspecies of the Mycobacterium tuberculosis complex on the basis of genomic deletions.

Authors:  Richard C Huard; Luiz Claudio de Oliveira Lazzarini; W Ray Butler; Dick van Soolingen; John L Ho
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

Review 5.  Disseminated bacille Calmette-Guérin disease after vaccination: case report and review.

Authors:  E A Talbot; M D Perkins; S F Silva; R Frothingham
Journal:  Clin Infect Dis       Date:  1997-06       Impact factor: 9.079

Review 6.  Bacillus Calmette-Guérin immunotherapy. Techniques and results.

Authors:  S A Brosman
Journal:  Urol Clin North Am       Date:  1992-08       Impact factor: 2.241

7.  Promising loci of variable numbers of tandem repeats for typing Beijing family Mycobacterium tuberculosis.

Authors:  Yoshiro Murase; Satoshi Mitarai; Isamu Sugawara; Seiya Kato; Shinji Maeda
Journal:  J Med Microbiol       Date:  2008-07       Impact factor: 2.472

8.  Mycobacterium bovis BCG vertebral osteomyelitis after intravesical BCG therapy, diagnosed by PCR-based genomic deletion analysis.

Authors:  Takuya Nikaido; Kei Ishibashi; Koji Otani; Shoji Yabuki; Shinichi Konno; Shuichi Mori; Kazutaka Ohashi; Takashi Ishida; Michiko Nakano; Osamu Yamaguchi; Tatsuo Suzutani; Shinichi Kikuchi
Journal:  J Clin Microbiol       Date:  2007-10-24       Impact factor: 5.948

9.  Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer.

Authors:  D L Lamm; P M van der Meijden; A Morales; S A Brosman; W J Catalona; H W Herr; M S Soloway; A Steg; F M Debruyne
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

10.  Novel Mycobacterium tuberculosis complex pathogen, M. mungi.

Authors:  Kathleen A Alexander; Pete N Laver; Anita L Michel; Mark Williams; Paul D van Helden; Robin M Warren; Nicolaas C Gey van Pittius
Journal:  Emerg Infect Dis       Date:  2010-08       Impact factor: 6.883
View more
  1 in total

Review 1.  Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

Authors:  María Asunción Pérez-Jacoiste Asín; Mario Fernández-Ruiz; Francisco López-Medrano; Carlos Lumbreras; Ángel Tejido; Rafael San Juan; Ana Arrebola-Pajares; Manuel Lizasoain; Santiago Prieto; José María Aguado
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.